Influence of recipient's HLA type on the outcome of renal transplantation.
Forsberg
B
B
Department of Medicine, Lund University, Malmö General Hospital, Sweden.
Ekberg
H
H
Johnson
U
U
D001379:Azathioprine / Q000008:administration & dosage; D002423:Cause of Death; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality; D006085:Graft Survival / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology*; D015234:HLA-A Antigens / Q000276:immunology; D015788:HLA-A1 Antigen / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology; D059947:HLA-B40 Antigen; D015795:HLA-B8 Antigen / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality; D011239:Prednisolone / Q000008:administration & dosage; D015996:Survival Rate
D006680:HLA Antigens; D015234:HLA-A Antigens; D015788:HLA-A1 Antigen; C043205:HLA-A19 antigen; D015235:HLA-B Antigens; D059947:HLA-B40 Antigen; D015795:HLA-B8 Antigen; D011239:Prednisolone; D001379:Azathioprine